Migraine Burden Among Women of Childbearing Age in China: Trends, Drivers, and Projections to 2045.
- 1Department of Neurology, Qianwei Hospital of Jilin Province, Changchun, People's Republic of China.
Abstract
Background
Migraine is a major cause of disability among women of childbearing age (WCBA), yet its long-term epidemiological burden in China remains incompletely characterized. This study systematically assessed temporal trends, age-specific patterns, underlying drivers, and future changes in migraine burden among Chinese WCBA.Methods
Migraine prevalence, incidence, disability-adjusted life years (DALYs), and corresponding age-standardized rates (ASRs) from 1990 to 2023 were obtained from GBD 2023. Temporal trends were assessed using estimated annual percentage change (EAPC) and Joinpoint regression with annual percentage change (APC) and average annual percentage change (AAPC). Das Gupta decomposition quantified demographic and epidemiological contributions, and Nordpred projected the burden through 2045.Results
From 1990 to 2023, prevalent migraine cases increased from 60,863,309 (95% uncertainty interval [UI]: 47,869,630-76,489,399) to 64,615,712 (95% UI: 50,835,902-79,970,949), and DALYs increased from 2,194,079 (95% UI: 1,407,590-3,107,661) to 2,353,368 (95% UI: 1,478,811-3,349,364), whereas incident cases decreased from 4,796,065 (95% UI: 3,119,766-6,910,062) to 4,663,573 (95% UI: 3,068,485-6,728,084). Given the relatively wide 95% UIs surrounding GBD estimates, these modest changes in absolute burden should be interpreted cautiously. Age-standardized prevalence, incidence, and DALY rates increased, with EAPCs of 0.25 (95% CI: 0.21-0.29), 0.20 (95% CI: 0.17-0.24), and 0.27 (95% CI: 0.23-0.31), respectively. Joinpoint regression yielded corresponding AAPCs of 0.20, 0.16, and 0.22. The highest absolute burden occurred among women aged 35-39 years. Epidemiological change was the largest positive contributor to increases in prevalence and DALYs, whereas demographic factors offset the positive epidemiological contribution to incidence. By 2045, prevalent cases, incident cases, and DALYs were projected to decline, while their corresponding ASRs were projected to increase.Conclusion
Migraine remains a substantial health burden among Chinese WCBA. The divergence between declining future absolute burden and increasing ASRs suggests that demographic factors may mask unfavorable epidemiological trends, highlighting the need for targeted prevention and long-term management in this population.
Related
- Tuberculosis disease burden trends, drivers, and projections to 2050 in China and the wider Central Asian region, 1990–2023
- Migraine burden inequities and 2050 projections in Africa based on global burden of disease 2023
- Divergent Trends and Widening Inequalities in Digestive Tract Cancers Among Women of Childbearing Age: A Global Analysis from 1990 to 2021 and Projections to 2050.
- Trends, decomposition, and projections of gout burden among middle-aged adults in China : GBD 2023
- Tobacco-attributable burden of alzheimer’s disease and other dementias in China and ASEAN : Temporal trends and projections – an observational study based on GBD 2021
BibTeX
@article{wang2026migraine,
title = {{Migraine Burden Among Women of Childbearing Age in China: Trends, Drivers, and Projections to 2045.}},
author = {Yingzhao Wang and Wenyu Li},
journal = {International journal of women's health},
year = {2026},
month = oct,
doi = {10.2147/ijwh.s648809},
url = {https://europepmc.org/article/MED/42960145},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Migraine Burden Among Women of Childbearing Age in China: Trends, Drivers, and Projections to 2045.
AU - Yingzhao Wang
AU - Wenyu Li
PY - 2026
DA - 2026/10/25
JO - International journal of women's health
DO - 10.2147/ijwh.s648809
UR - https://europepmc.org/article/MED/42960145
AB - Background Migraine is a major cause of disability among women of childbearing age (WCBA), yet its long-term epidemiological burden in China remains incompletely characterized. This study systematically assessed temporal trends, age-specific patterns, underlying drivers, and future changes in migraine burden among Chinese WCBA.Methods Migraine prevalence, incidence, disability-adjusted life years (DALYs), and corresponding age-standardized rates (ASRs) from 1990 to 2023 were obtained from GBD 2023. Temporal trends were assessed using estimated annual percentage change (EAPC) and Joinpoint regression with annual percentage change (APC) and average annual percentage change (AAPC). Das Gupta decomposition quantified demographic and epidemiological contributions, and Nordpred projected the burden through 2045.Results From 1990 to 2023, prevalent migraine cases increased from 60,863,309 (95% uncertainty interval [UI]: 47,869,630-76,489,399) to 64,615,712 (95% UI: 50,835,902-79,970,949), and DALYs increased from 2,194,079 (95% UI: 1,407,590-3,107,661) to 2,353,368 (95% UI: 1,478,811-3,349,364), whereas incident cases decreased from 4,796,065 (95% UI: 3,119,766-6,910,062) to 4,663,573 (95% UI: 3,068,485-6,728,084). Given the relatively wide 95% UIs surrounding GBD estimates, these modest changes in absolute burden should be interpreted cautiously. Age-standardized prevalence, incidence, and DALY rates increased, with EAPCs of 0.25 (95% CI: 0.21-0.29), 0.20 (95% CI: 0.17-0.24), and 0.27 (95% CI: 0.23-0.31), respectively. Joinpoint regression yielded corresponding AAPCs of 0.20, 0.16, and 0.22. The highest absolute burden occurred among women aged 35-39 years. Epidemiological change was the largest positive contributor to increases in prevalence and DALYs, whereas demographic factors offset the positive epidemiological contribution to incidence. By 2045, prevalent cases, incident cases, and DALYs were projected to decline, while their corresponding ASRs were projected to increase.Conclusion Migraine remains a substantial health burden among Chinese WCBA. The divergence between declining future absolute burden and increasing ASRs suggests that demographic factors may mask unfavorable epidemiological trends, highlighting the need for targeted prevention and long-term management in this population.
SN - 1179-1411
ER -